Premier Biomedical, Inc. (BIEI)
Stock Price Chart
Key Info
| Market Cap | 999,981 |
| Revenue (ttm) | 14,281 |
| Net Income (ttm) | -374,470 |
| Shares Out | 999.98M |
| EPS (ttm) | -0.01 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Dividend Yield | n/a |
Stock Quote
| Trading Day | November 27 |
| Last Price | $0.0010 |
| Previous Close | $0.0010 |
| Change ($) | 0.0000 |
| Change (%) | 0.00% |
| Day's Open | 0.0010 |
| Day's Range | 0.0009 - 0.0010 |
| Day's Volume | 4,474,089 |
| 52-Week Range | 0.0002 - 0.0084 |
More Stats
| Market Cap | 999,981 |
| Enterprise Value | 928,784 |
| Earnings Date (est) | n/a |
| Ex-Dividend Date | n/a |
| Shares Outstanding | 999.98M |
| Float | n/a |
| EPS (basic) | -0.01 |
| EPS (diluted) | -0.01 |
| FCF / Share | -0.01 |
| Dividend | n/a |
| Dividend Yield | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
| Payout Ratio | n/a |
| Shares Short | n/a |
| Short Ratio | n/a |
| Short % of Float | n/a |
| Beta | -6.29 |
| PE Ratio | n/a |
| Forward PE | n/a |
| P/FCF Ratio | n/a |
| PS Ratio | 70.02 |
| PB Ratio | n/a |
| Revenue | 14,281 |
| Operating Income | -326,735 |
| Net Income | -374,470 |
| Free Cash Flow | -349,030 |
| Net Cash | 71,197 |
| Net Cash / Share | 0.00 |
| Gross Margin | 9.95% |
| Operating Margin | -2,287.90% |
| Profit Margin | -2,622.20% |
| FCF Margin | -2,444.02% |
| ROA | -153.58% |
| ROE | n/a |
| ROIC | -0.90% |
Analyst Forecasts
Analyst Consensus: n/a
Financial Performance
Financial Overview
| Year | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0.01 | 0.04 | 0.04 | - | - | - | - | - | - |
| Revenue Growth | -64.11% | 0.09% | - | - | - | - | - | - | - |
| Gross Profit | - | -0.07 | 0.01 | - | - | - | - | - | - |
| Operating Income | -0.33 | -0.69 | -1.29 | -0.64 | -2.38 | -1.37 | -4.48 | -1.71 | -0.11 |
| Net Income | -0.37 | -0.40 | -3.76 | -1.77 | -2.60 | -1.41 | -4.88 | -1.71 | -0.11 |
| Shares Outstanding | 52.40 | 3.51 | 1.96 | 0.15 | 0.13 | 0.08 | 0.06 | 0.05 | 0.04 |
| Earnings Per Share | -0.01 | -0.11 | -1.92 | -0.01 | -20.00 | -17.50 | -77.50 | -37.50 | -2.50 |
| Operating Cash Flow | -0.34 | -0.44 | -0.51 | -0.48 | -0.46 | -0.64 | -0.43 | -0.13 | -0.09 |
| Capital Expenditures | - | - | - | - | - | - | - | -0.01 | -0.01 |
| Free Cash Flow | -0.35 | -0.45 | -0.51 | -0.49 | -0.46 | -0.64 | -0.43 | -0.14 | -0.10 |
| Cash & Equivalents | 0.07 | 0.09 | 0.08 | 0.02 | 0.04 | 0.10 | 0.02 | 0.04 | 0.03 |
| Total Debt | - | - | 0.17 | 0.18 | 0.07 | 0.01 | 0.11 | 0.01 | - |
| Net Cash / Debt | 0.07 | 0.09 | -0.09 | -0.16 | -0.04 | 0.09 | -0.09 | 0.03 | 0.03 |
| Assets | 0.10 | 0.16 | 0.21 | 0.04 | 0.05 | 0.12 | 0.03 | 0.04 | 0.03 |
| Liabilities | 1.93 | 2.31 | 2.82 | 0.70 | 0.47 | 0.19 | 0.27 | 0.12 | - |
| Book Value | -1.83 | -2.15 | -2.61 | -0.66 | -0.43 | -0.07 | -0.25 | -0.08 | 0.03 |
Company Profile
Company Details
| Full Name | Premier Biomedical, Inc. |
| Country | United States |
Stock Information
| Ticker Symbol | BIEI |
| Stock Exchange | US OTC |
| Sector | Healthcare |
| Industry | Drug Manufacturers—Specialty & Generic |
| Unique Identifier | OTCMKTS: BIEI |
Description
Premier Biomedical, a research-based company, discovers and develops medical products for the treatment of PTSD, cancer, and various other diseases. It offers pain management products comprising pain relief patch of hemp oil extracts; water-based and oil-based roll-on applicators; oil-based pump spray applicators; and ointments through its Website painreliefmeds.com and various distributors. It is also developing hemp oil products, including anti-pain patch, roll-on topical products, sprays, ointments, tincture drop product, a hemp oil capsule, and pet product; sequential-dialysis technique for cancer, Alzheimer's disease, ALS, blood sepsis, leukemia, and other life-threatening cancers; and Feldetrex drug candidate for the treatment of multiple sclerosis, fibromyalgia, neuropathic pain, and traumatic brain injuries. Premier Biomedical, Inc. was founded in 2010 and is headquartered in Jackson Center, Pennsylvania.